Inventor
CHOWDHURY SULTAN
CA44 patents
⚠️ This page may combine multiple inventors who share the name “CHOWDHURY SULTAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENON PHARMACEUTICALS INC
18 patentsUS7335658B2Feb 26, 2008
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC59 citations97
US7799798B2Sep 21, 2010
Spiroheterocyclic compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC26 citations92
US7700641B2Apr 20, 2010
Spiro-oxindole compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC39 citations92
US10815229B1Oct 27, 2020
Benzenesulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC4 citations83
US8916580B2Dec 23, 2014
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC4 citations83
US7919484B2Apr 5, 2011
Combination therapy
XENON PHARMACEUTICALS INC10 citations83
US7777036B2Aug 17, 2010
Heterocyclic derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC13 citations83
US10246453B2Apr 2, 2019
Benzenesulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC10 citations82
US9260446B2Feb 16, 2016
Synthetic methods for spiro-oxindole compounds
XENON PHARMACEUTICALS INC4 citations81
US9487535B2Nov 8, 2016
Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
XENON PHARMACEUTICALS INC5 citations73
US11299490B2Apr 12, 2022
Benzenesulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC3 citations71
US11174268B2Nov 16, 2021
Benzenesulfonamide compouds and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations71
US10662184B2May 26, 2020
Benzenesulfonamide compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC4 citations71
US9695185B2Jul 4, 2017
Synthetic methods for spiro-oxindole compounds
XENON PHARMACEUTICALS INC3 citations71
US7754711B2Jul 13, 2010
Pyridazine derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC2 citations62
US9458178B2Oct 4, 2016
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC1 citations61
US7829712B2Nov 9, 2010
Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
XENON PHARMACEUTICALS INC1 citations52
US7951805B2May 31, 2011
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
XENON PHARMACEUTICALS INC0 citations41
GENENTECH INC
17 patentsUS8933236B2Jan 13, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC50 citations97
US8952169B2Feb 10, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC25 citations92
US9771376B2Sep 26, 2017
N-substituted benzamides and methods of use thereof
GENENTECH INC7 citations84
US9493429B2Nov 15, 2016
Substituted benzoxazoles and methods of use thereof
GENENTECH INC10 citations84
US10005724B2Jun 26, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC6 citations83
US9694002B2Jul 4, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC11 citations83
US9546164B2Jan 17, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC13 citations83
US10526285B2Jan 7, 2020
Therapeutic compounds and methods of use thereof
GENENTECH INC1 citations72
US10125098B2Nov 13, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC2 citations72
US9550775B2Jan 24, 2017
Substituted triazolopyridines and methods of use thereof
GENENTECH INC7 citations72
US11203572B2Dec 21, 2021
Substituted benzamides and methods of use thereof
GENENTECH INC0 citations62
US10766858B2Sep 8, 2020
Substituted benzamides and methods of use thereof
GENENTECH INC1 citations62
US11149002B2Oct 19, 2021
Therapeutic compounds and methods of use thereof
GENENTECH INC0 citations61
US10787446B2Sep 29, 2020
Therapeutic compounds and methods of use thereof
GENENTECH INC1 citations59
US10071957B2Sep 11, 2018
N-substituted benzamides and methods of use thereof
GENENTECH INC1 citations52
US10179767B2Jan 15, 2019
Substituted benzamides and methods of use thereof
GENENTECH INC0 citations51
US10899732B2Jan 26, 2021
Substituted benzamides useful as sodium channel blockers
GENENTECH INC0 citations48
CHAFEEV MIKHAIL
5 patentsUS8466188B2Jun 18, 2013
Use of spiro-oxindole compounds as therapeutic agents
CHAFEEV MIKHAIL63 citations97
US8106087B2Jan 31, 2012
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL19 citations92
US8263606B2Sep 11, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL16 citations91
US8101647B2Jan 24, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL35 citations91
US8415370B2Apr 9, 2013
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL10 citations82